ConductScience.org, home

Trial · NCT07909928

Registered outcomes19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryOsteochondral Allograft Incorporation Assessed by MRI6 months after surgery
Osteochondral allograft incorporation will be assessed using magnetic resonance imaging (MRI) at 6 months after surgery. MRI findings will be evaluated using the Osteochondral Allograft MRI Scoring System (OCAMRISS) and other radiographic indicators of graft incorporation. Results will be summarized descriptively.
SecondaryOsteochondral Allograft Incorporation at 12 Weeks12 weeks after surgery
Osteochondral allograft incorporation will be assessed using MRI at 12 weeks after surgery. MRI findings will be evaluated using OCAMRISS and other radiographic indicators of graft incorporation and summarized descriptively.
SecondaryOsteochondral Allograft Incorporation at 12 Months12 months after surgery, if clinically indicated
Additional MRI evaluation will be performed at 12 months for participants with incomplete graft incorporation at the 6-month assessment. Graft incorporation will be assessed using OCAMRISS and other MRI indicators of graft healing.
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)Baseline, 1 week, 6 weeks, 12 weeks, 6 months, and 1 year after surgery
Patient-reported knee symptoms and function will be evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and scheduled postoperative follow-up visits. Changes in KOOS scores over time will be summarized descriptively.
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)Baseline
Patient-reported knee symptoms and function will be evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and scheduled postoperative follow-up visits. Changes in KOOS scores over time will be summarized descriptively.
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)1 week
Patient-reported knee symptoms and function will be evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and scheduled postoperative follow-up visits. Changes in KOOS scores over time will be summarized descriptively.
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)6 weeks
Patient-reported knee symptoms and function will be evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and scheduled postoperative follow-up visits. Changes in KOOS scores over time will be summarized descriptively.
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)12 weeks
Patient-reported knee symptoms and function will be evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and scheduled postoperative follow-up visits. Changes in KOOS scores over time will be summarized descriptively.
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)6 months
Patient-reported knee symptoms and function will be evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and scheduled postoperative follow-up visits. Changes in KOOS scores over time will be summarized descriptively.
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)1 year after surgery
Patient-reported knee symptoms and function will be evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at baseline and scheduled postoperative follow-up visits. Changes in KOOS scores over time will be summarized descriptively.
SecondaryChange in Pain Measured by Visual Analog Scale (VAS)BaselinePatient-reported pain will be assessed using a Visual Analog Scale (VAS) at baseline and scheduled postoperative follow-up visits. Changes in pain ratings over time will be summarized descriptively.
SecondaryChange in Pain Measured by Visual Analog Scale (VAS)1 weekPatient-reported pain will be assessed using a Visual Analog Scale (VAS) at baseline and scheduled postoperative follow-up visits. Changes in pain ratings over time will be summarized descriptively.
SecondaryChange in Pain Measured by Visual Analog Scale (VAS)6 weeksPatient-reported pain will be assessed using a Visual Analog Scale (VAS) at baseline and scheduled postoperative follow-up visits. Changes in pain ratings over time will be summarized descriptively.
SecondaryChange in Pain Measured by Visual Analog Scale (VAS)12 weeksPatient-reported pain will be assessed using a Visual Analog Scale (VAS) at baseline and scheduled postoperative follow-up visits. Changes in pain ratings over time will be summarized descriptively.
SecondaryChange in Pain Measured by Visual Analog Scale (VAS)6 monthsPatient-reported pain will be assessed using a Visual Analog Scale (VAS) at baseline and scheduled postoperative follow-up visits. Changes in pain ratings over time will be summarized descriptively.
SecondaryChange in Pain Measured by Visual Analog Scale (VAS)1 year after surgeryPatient-reported pain will be assessed using a Visual Analog Scale (VAS) at baseline and scheduled postoperative follow-up visits. Changes in pain ratings over time will be summarized descriptively.
SecondaryRadiographic Evidence of Graft Incorporation and HealingThrough 1 year after surgery
Radiographic evidence of osteochondral allograft incorporation and healing will be evaluated using standard-of-care postoperative radiographs obtained throughout the follow-up period. Radiographic findings will be summarized descriptively.
SecondaryPostoperative Complications and Adverse EventsFrom surgery through 1 year after surgery
Postoperative complications and adverse events related to osteochondral allograft transplantation and biologic augmentation will be collected through clinical follow-up and review of medical records during the 1-year postoperative period.
SecondarySubsequent Procedures Related to Index SurgeryFrom surgery through 1 year after surgerySubsequent surgical or other procedures related to the index osteochondral allograft transplantation will be recorded during the 1-year postoperative follow-up period.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07909928/registered